The Trump administration today asked Congress again to require 340B covered entities to report their 340B program savings and uses to the Health Resources and Services Administration (HRSA).
The administration made the request in its proposed federal budget for fiscal year 2021. The budget also again asks Congress to give HRSA general regulatory over the 340B program and to approve a 0.1 percent user fee on 340B program drug sales paid by participating covered entities.
The Trump administration today asked Congress again to require 340B covered entities to report their 340B program savings and uses to the Health Resources and Services Administration (HRSA). The administration made the request in its proposed federal budget for fiscal
...
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.